Amylin Pharmaceuticals, Inc.'s Diabetes Drug Pramlintide May Help Treat Obesity

NEW YORK (Reuters Health) - Obese men and women may enhance a weight-loss program of lifestyle changes by adding a drug to lower blood sugar levels, researchers report. , currently approved by the FDA for diabetes to take in combination with insulin to control their blood sugar levels. Previous research also linked pramlintide to weight loss, report Dr. Christian Weyer, of Amylin Pharmaceuticals in San Diego, California, and colleagues.

Back to news